SEC Form 4 · accession 0001209191-18-005999
MARINEMAX INC · HZO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael H McLamb
Officer — Executive VP, CFO and Sec · Director
Period of report
Jan 26, 2018
Accepted (ET)
Jan 30, 2018 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001057060
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 26, 2018 | M | 25,000 | $6.10 | A | 171,456 | D | |
| Common StockF2 | Jan 26, 2018 | S | 25,000 | $23.92 | D | 146,456 | D | |
| Common StockF4 | Jan 26, 2018 | S | 25,000 | $24.08 | D | 121,456 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F5 | $6.10 | Jan 26, 2018 | M | 25,000 | D | — | Nov 18, 2021 | Common Stock | 25,000 | 10,000 | D |
Explanation of responses
- F1The shares were exercised and sold pursuant to a 10b5-1 Sales Plan.
- F2This transaction was executed in multiple trades at prices ranging from $23.80 to $24.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F3The shares were sold pursuant to a 10b5-1 Sales Plan.
- F4This transaction was executed in multiple trades at prices ranging from $24.05 to $24.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F51/36 of the options granted vested and became exercisable on a monthly basis for a three-year period beginning on the grant date.